{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T12:08:08Z","timestamp":1790424488082,"version":"4.1.0"},"reference-count":26,"publisher":"American Society of Hematology","issue":"3","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,7,16]]},"abstract":"<jats:sec>\n                    <jats:title>Abstract<\/jats:title>\n                    <jats:p>Intensified chemotherapy regimens have improved outcomes in adults with Philadelphia chromosome\u2013negative (Ph\u2212) B-cell acute lymphoblastic leukemia (B-ALL), yet relapse remains a major cause of treatment failure and death. Blinatumomab is a T-cell engager that demonstrated marked activity in relapsed and measurable residual disease\u2013positive (MRD+) B-ALL, as well as in frontline consolidation for MRD\u2212 patients. The phase 2 GRAALL-2014\/B-QUEST substudy evaluated the integration of blinatumomab into consolidation and maintenance therapy for adults with high-risk (HR) B-ALL. Between 2015 and 2020, 489 adults aged 18 to 59 years with newly diagnosed Ph\u2212 B-ALL were enrolled, and among these 259 were classified as HR (presence of KMT2A-r, IKZF1 deletion, or end-of-induction MRD \u2265 10\u20134). A total of 94 patients with HR were enrolled in the QUEST study (2018-2020) and received up to 5, 28-day cycles of blinatumomab during consolidation and maintenance. In addition, 90 patients with HR who were treated before QUEST activation without blinatumomab served as controls in a post hoc analysis. Baseline characteristics were comparable between groups. Blinatumomab consolidation significantly improved MRD clearance, reduced relapse, and prolonged survival. At 5 years, cumulative incidence of relapse, disease-free survival (DFS), and overall survival were 23%, 68%, and 79% in the blinatumomab group compared with 49% (P = .001), 42% (P = .001), and 60% (P = .03) in controls. Patients eligible for allogeneic hematopoietic stem cell transplantation (alloHSCT) derived overall benefit. However, no clear additional DFS advantage was observed among those who ultimately underwent transplantation. These findings support the frontline integration of blinatumomab and warrant prospective evaluation of transplantation strategies in this setting. This trial was registered at www.clinicaltrials.gov as #NCT03709719.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1182\/blood.2026033309","type":"journal-article","created":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T14:49:40Z","timestamp":1778683780000},"page":"289-299","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":7,"title":["Blinatumomab consolidation for high-risk Ph\u2212 B-cell acute lymphoblastic leukemia: the GRAALL-2014\/B-QUEST study"],"prefix":"10.1182","volume":"148","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2091-7927","authenticated-orcid":false,"given":"Nicolas","family":"Boissel","sequence":"first","affiliation":[{"name":"1D\u00e9partement d\u2019H\u00e9matologie, H\u00f4pital Saint-Louis, Assistance Publique-H\u00f4pitaux de Paris, Paris, France"},{"name":"2Institut de Recherche Saint-Louis, Universit\u00e9 Paris Cit\u00e9, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9576-8578","authenticated-orcid":false,"given":"Fran\u00e7oise","family":"Huguet","sequence":"additional","affiliation":[{"name":"3Service d\u2019H\u00e9matologie, Institut Universitaire du Cancer de Toulouse-Oncopole, Centre Hospitalier Universitaire de Toulouse, Toulouse, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3123-4948","authenticated-orcid":false,"given":"Thibaut","family":"Leguay","sequence":"additional","affiliation":[{"name":"4Service d\u2019H\u00e9matologie, Centre Hospitalier Universitaire de Bordeaux, H\u00f4pital du Haut-L\u00e9v\u00eaque, Pessac, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7777-5216","authenticated-orcid":false,"given":"Mathilde","family":"Hunault","sequence":"additional","affiliation":[{"name":"5Service d\u2019H\u00e9matologie, Centre Hospitalier Universitaire d\u2019Angers, Angers, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9987-7237","authenticated-orcid":false,"given":"Rathana","family":"Kim","sequence":"additional","affiliation":[{"name":"2Institut de Recherche Saint-Louis, Universit\u00e9 Paris Cit\u00e9, Paris, France"},{"name":"6Service d\u2019H\u00e9matologie Biologique, H\u00f4pital Saint-Louis, Assistance Publique-H\u00f4pitaux de Paris, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4508-9921","authenticated-orcid":false,"given":"Yosr","family":"Hicheri","sequence":"additional","affiliation":[{"name":"7Service d\u2019H\u00e9matologie, Institut Paoli-Calmettes, Marseille, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4620-8782","authenticated-orcid":false,"given":"Marie","family":"Passet","sequence":"additional","affiliation":[{"name":"2Institut de Recherche Saint-Louis, Universit\u00e9 Paris Cit\u00e9, Paris, France"},{"name":"6Service d\u2019H\u00e9matologie Biologique, H\u00f4pital Saint-Louis, Assistance Publique-H\u00f4pitaux de Paris, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3142-5581","authenticated-orcid":false,"given":"Patrice","family":"Chevallier","sequence":"additional","affiliation":[{"name":"8Service d\u2019H\u00e9matologie, Centre Hospitalier Universitaire de Nantes, Nantes, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2973-6751","authenticated-orcid":false,"given":"Marie","family":"Balsat","sequence":"additional","affiliation":[{"name":"9Service d\u2019H\u00e9matologie, Hospices Civils de Lyon, H\u00f4pital Lyon Sud, Pierre-B\u00e9nite, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5675-3154","authenticated-orcid":false,"given":"C\u00e9dric","family":"Pastoret","sequence":"additional","affiliation":[{"name":"10Laboratoire d\u2019H\u00e9matologie, Centre Hospitalier Universitaire de Rennes, Rennes, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0928-0753","authenticated-orcid":false,"given":"Eric","family":"Delabesse","sequence":"additional","affiliation":[{"name":"11Laboratoire d\u2019H\u00e9matologie, Institut Universitaire du Cancer de Toulouse-Oncopole, Centre Hospitalier Universitaire de Toulouse, Toulouse, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1170-8683","authenticated-orcid":false,"given":"S\u00e9bastien","family":"Maury","sequence":"additional","affiliation":[{"name":"12Service d\u2019H\u00e9matologie Clinique, H\u00f4pital Henri-Mondor, Assistance Publique-H\u00f4pitaux de Paris, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3984-0934","authenticated-orcid":false,"given":"Anne","family":"Thiebaut-Bertrand","sequence":"additional","affiliation":[{"name":"13Service d\u2019H\u00e9matologie, Centre Hospitalier Universitaire Grenoble Alpes, Grenoble, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florence","family":"Van Obbergh","sequence":"additional","affiliation":[{"name":"14Service d\u2019H\u00e9matologie, Centre Hospitalier Universitaire HELORA\u2013H\u00f4pital de La Louvi\u00e8re\/Jolimont, La Louvi\u00e8re, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6745-1127","authenticated-orcid":false,"given":"Thomas","family":"Cluzeau","sequence":"additional","affiliation":[{"name":"15Service d\u2019H\u00e9matologie, Centre Hospitalier Universitaire de Nice, Nice, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-7835-4350","authenticated-orcid":false,"given":"Martine","family":"Escoffre-Barbe","sequence":"additional","affiliation":[{"name":"16Service d\u2019H\u00e9matologie, Centre Hospitalier Universitaire de Rennes, Rennes, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0199-8821","authenticated-orcid":false,"given":"Nicole","family":"Straetmans","sequence":"additional","affiliation":[{"name":"17Service d\u2019H\u00e9matologie, Cliniques Universitaires Saint-Luc, Universit\u00e9 Catholique de Louvain, Brussels, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-3140-3379","authenticated-orcid":false,"given":"Johanna","family":"Konopacki","sequence":"additional","affiliation":[{"name":"18Service d\u2019H\u00e9matologie, H\u00f4pital d\u2019Instruction des Arm\u00e9es Percy, Clamart, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0870-4830","authenticated-orcid":false,"given":"Amine","family":"Belhabri","sequence":"additional","affiliation":[{"name":"19Service d\u2019H\u00e9matologie, Centre L\u00e9on-B\u00e9rard, Lyon, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5737-9934","authenticated-orcid":false,"given":"Alban","family":"Villate","sequence":"additional","affiliation":[{"name":"20Service d\u2019H\u00e9matologie, Centre Hospitalier R\u00e9gional Universitaire de Tours, Tours, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1432-5300","authenticated-orcid":false,"given":"Florence","family":"Pasquier","sequence":"additional","affiliation":[{"name":"21D\u00e9partement d\u2019H\u00e9matologie, Gustave Roussy, Universit\u00e9 Paris Saclay, Villejuif, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ioana","family":"Vaida","sequence":"additional","affiliation":[{"name":"22Service d\u2019H\u00e9matologie, H\u00f4pital Ren\u00e9-Dubos (Nord-Ouest Val-d'Oise), Pontoise, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1207-7665","authenticated-orcid":false,"given":"Laurence","family":"Sanhes","sequence":"additional","affiliation":[{"name":"23Service d\u2019H\u00e9matologie, Centre Hospitalier de Perpignan, Perpignan, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2275-3081","authenticated-orcid":false,"given":"Sabine","family":"Blum","sequence":"additional","affiliation":[{"name":"24Service d\u2019H\u00e9matologie, Centre Hospitalier Universitaire Vaudois, Universit\u00e9 de Lausanne, Lausanne, Switzerland"},{"name":"25Swiss Group for Clinical Cancer Research, Bern, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Magda","family":"Alexis","sequence":"additional","affiliation":[{"name":"26Service d\u2019H\u00e9matologie, Centre Hospitalier R\u00e9gional d\u2019Orl\u00e9ans, Orl\u00e9ans, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mathilde","family":"Lamarque","sequence":"additional","affiliation":[{"name":"27Service d\u2019H\u00e9matologie, Groupe Hospitalier R\u00e9gional Mulhouse Sud-Alsace, H\u00f4pital \u00c9mile-Muller, Mulhouse, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laure","family":"Farnault","sequence":"additional","affiliation":[{"name":"28Service d\u2019H\u00e9matologie, Assistance Publique-H\u00f4pitaux de Marseille\u2013H\u00f4pital de la Conception, Marseille, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3474-2577","authenticated-orcid":false,"given":"C\u00e9line","family":"Berthon","sequence":"additional","affiliation":[{"name":"29Service d\u2019H\u00e9matologie, Centre Hospitalier Universitaire de Lille, H\u00f4pital Claude-Huriez, Lille, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6901-9234","authenticated-orcid":false,"given":"V\u00e9ronique","family":"Lh\u00e9ritier","sequence":"additional","affiliation":[{"name":"30Group for Research on Adult Acute Lymphoblastic Leukemia, H\u00f4pital Lyon Sud, Pierre-B\u00e9nite, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3063-850X","authenticated-orcid":false,"given":"Norbert","family":"Ifrah","sequence":"additional","affiliation":[{"name":"5Service d\u2019H\u00e9matologie, Centre Hospitalier Universitaire d\u2019Angers, Angers, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9236-3623","authenticated-orcid":false,"given":"Carlos","family":"Graux","sequence":"additional","affiliation":[{"name":"31Service d\u2019H\u00e9matologie, Centre Hospitalier Universitaire, Universit\u00e9 Catholique de Louvain Namur\u2013Site Godinne, Yvoir, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9341-8104","authenticated-orcid":false,"given":"Yves","family":"Chalandon","sequence":"additional","affiliation":[{"name":"25Swiss Group for Clinical Cancer Research, Bern, Switzerland"},{"name":"32Service d\u2019H\u00e9matologie, Department of Oncology, H\u00f4pitaux Universitaires de Gen\u00e8ve and Medical School, University of Geneva, Geneva, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7098-092X","authenticated-orcid":false,"given":"Emmanuelle","family":"Clappier","sequence":"additional","affiliation":[{"name":"2Institut de Recherche Saint-Louis, Universit\u00e9 Paris Cit\u00e9, Paris, France"},{"name":"6Service d\u2019H\u00e9matologie Biologique, H\u00f4pital Saint-Louis, Assistance Publique-H\u00f4pitaux de Paris, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5454-6768","authenticated-orcid":false,"given":"Herv\u00e9","family":"Dombret","sequence":"additional","affiliation":[{"name":"1D\u00e9partement d\u2019H\u00e9matologie, H\u00f4pital Saint-Louis, Assistance Publique-H\u00f4pitaux de Paris, Paris, France"},{"name":"2Institut de Recherche Saint-Louis, Universit\u00e9 Paris Cit\u00e9, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","reference":[{"issue":"4","key":"2026071611215337400_bib1","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1182\/blood-2018-02-778530","article-title":"Acute lymphoblastic leukemia in adolescent and young adults: treat as adults or as children?","volume":"132","author":"Boissel","year":"2018","journal-title":"Blood"},{"issue":"19","key":"2026071611215337400_bib2","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.1182\/blood.2023023568","article-title":"Management of ALL in adults: 2024 ELN recommendations from a European expert panel","volume":"143","author":"G\u00f6kbuget","year":"2024","journal-title":"Blood"},{"issue":"6","key":"2026071611215337400_bib3","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1200\/JCO.2008.18.6916","article-title":"Pediatric-inspired therapy in adults with Philadelphia chromosome-negative acute lymphoblastic leukemia: the GRAALL-2003 study","volume":"27","author":"Huguet","year":"2009","journal-title":"J Clin Oncol"},{"issue":"14","key":"2026071611215337400_bib4","doi-asserted-by":"crossref","first-page":"1548","DOI":"10.1182\/blood-2018-10-881961","article-title":"A pediatric regimen for older adolescents and young adults with acute lymphoblastic leukemia: results of CALGB 10403","volume":"133","author":"Stock","year":"2019","journal-title":"Blood"},{"issue":"22","key":"2026071611215337400_bib5","doi-asserted-by":"crossref","DOI":"10.1182\/blood.V128.22.762.762","article-title":"The upper age limit for a pediatric-inspired therapy in younger adults with Ph-negative acute lymphoblastic leukemia (ALL)? Analysis of the GRAALL-2005 study","volume":"128","author":"Huguet","year":"2016","journal-title":"Blood"},{"issue":"7","key":"2026071611215337400_bib6","doi-asserted-by":"crossref","first-page":"1758","DOI":"10.3324\/haematol.2022.281820","article-title":"General condition and comorbidity of long-term survivors of adult acute lymphoblastic leukemia","volume":"108","author":"G\u00f6kbuget","year":"2023","journal-title":"Haematologica"},{"key":"2026071611215337400_bib7","first-page":"796426","article-title":"Haematopoietic stem cell transplantation in adolescents and young adults with acute lymphoblastic leukaemia: special considerations and challenges","volume":"11(9)","author":"Calvo","year":"2021","journal-title":"Front Pediatr"},{"issue":"18","key":"2026071611215337400_bib8","doi-asserted-by":"crossref","first-page":"4035","DOI":"10.1158\/1078-0432.CCR-15-0612","article-title":"FDA approval: blinatumomab","volume":"21","author":"Przepiorka","year":"2015","journal-title":"Clin Cancer Res"},{"issue":"9","key":"2026071611215337400_bib9","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1056\/NEJMoa1609783","article-title":"Blinatumomab versus chemotherapy for advanced acute lymphoblastic leukemia","volume":"376","author":"Kantarjian","year":"2017","journal-title":"N Engl J Med"},{"issue":"16","key":"2026071611215337400_bib10","doi-asserted-by":"crossref","first-page":"1795","DOI":"10.1200\/JCO.2016.69.3531","article-title":"Complete hematologic and molecular response in adult patients with relapsed\/refractory Philadelphia chromosome-positive B-precursor acute lymphoblastic leukemia following treatment with blinatumomab: results from a phase II, single-arm, multicenter study","volume":"35","author":"Martinelli","year":"2017","journal-title":"J Clin Oncol"},{"issue":"14","key":"2026071611215337400_bib11","doi-asserted-by":"crossref","first-page":"1522","DOI":"10.1182\/blood-2017-08-798322","article-title":"Blinatumomab for minimal residual disease in adults with B-cell precursor acute lymphoblastic leukemia","volume":"131","author":"G\u00f6kbuget","year":"2018","journal-title":"Blood"},{"issue":"4","key":"2026071611215337400_bib12","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1056\/NEJMoa2312948","article-title":"Blinatumomab for MRD-negative acute lymphoblastic leukemia in adults","volume":"391","author":"Litzow","year":"2024","journal-title":"N Engl J Med"},{"issue":"24","key":"2026071611215337400_bib13","doi-asserted-by":"crossref","first-page":"3739","DOI":"10.1182\/blood-2014-01-547695","article-title":"Oncogenetics and minimal residual disease are independent outcome predictors in adult patients with acute lymphoblastic leukemia","volume":"123","author":"Beldjord","year":"2014","journal-title":"Blood"},{"issue":"8","key":"2026071611215337400_bib14","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1182\/blood.2025029611","article-title":"Age-adapted chemotherapy and MRD-oriented transplant for Ph-negative acute lymphoblastic leukemia: the GRAALL-2014 trial","volume":"147","author":"Boissel","year":"2026","journal-title":"Blood"},{"issue":"4","key":"2026071611215337400_bib15","doi-asserted-by":"crossref","first-page":"597","DOI":"10.3324\/haematol.2012.073965","article-title":"Breakpoint-specific multiplex polymerase chain reaction allows the detection of IKZF1 intragenic deletions and minimal residual disease monitoring in B-cell precursor acute lymphoblastic leukemia","volume":"98","author":"Caye","year":"2013","journal-title":"Haematologica"},{"issue":"16","key":"2026071611215337400_bib16","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1182\/blood.2019001244","article-title":"Efficacy of tyrosine kinase inhibitors in Ph-like acute lymphoblastic leukemia harboring ABL-class rearrangements","volume":"134","author":"Tanasi","year":"2019","journal-title":"Blood"},{"issue":"446","key":"2026071611215337400_bib17","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1080\/01621459.1999.10474144","article-title":"A Proportional Hazards Model for the Subdistribution of a Competing Risk","volume":"94","author":"Fine","year":"1999","journal-title":"J Am Stat Assoc"},{"issue":"1","key":"2026071611215337400_bib18","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1093\/biomet\/69.1.239","article-title":"Partial residuals for the proportional hazards regression model","volume":"69","author":"Schoenfeld","year":"1982","journal-title":"Biometrika"},{"issue":"3","key":"2026071611215337400_bib19","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1093\/biomet\/81.3.515","article-title":"Proportional hazards tests and diagnostics based on weighted residuals","volume":"81","author":"Grambsch","year":"1994","journal-title":"Biometrika"},{"issue":"12","key":"2026071611215337400_bib20","doi-asserted-by":"crossref","first-page":"e878","DOI":"10.1016\/S2352-3026(22)00285-X","article-title":"Hyper-CVAD and sequential blinatumomab for newly diagnosed Philadelphia chromosome-negative B-cell acute lymphocytic leukaemia: a single-arm, single-centre, phase 2 trial","volume":"9","author":"Jabbour","year":"2022","journal-title":"Lancet Haematol"},{"issue":"21","key":"2026071611215337400_bib21","doi-asserted-by":"crossref","first-page":"2447","DOI":"10.1182\/blood.2024027500","article-title":"Up-front blinatumomab improves MRD clearance and outcome in adult Ph- B-lineage ALL: the GIMEMA LAL2317 phase 2 study","volume":"145","author":"Bassan","year":"2025","journal-title":"Blood"},{"issue":"17","key":"2026071611215337400_bib22","doi-asserted-by":"crossref","first-page":"1572","DOI":"10.1056\/NEJMoa2214171","article-title":"Blinatumomab added to chemotherapy in infant lymphoblastic leukemia","volume":"388","author":"van der Sluis","year":"2023","journal-title":"N Engl J Med"},{"issue":"9","key":"2026071611215337400_bib23","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1056\/NEJMoa2411680","article-title":"Blinatumomab in standard-risk B-cell acute lymphoblastic leukemia in children","volume":"392","author":"Gupta","year":"2025","journal-title":"N Engl J Med"},{"issue":"4","key":"2026071611215337400_bib24","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1182\/blood.2024026655","article-title":"Project EVOLVE: an international analysis of postimmunotherapy lineage switch, an emergent form of relapse in leukemia","volume":"146","author":"Silbert","year":"2025","journal-title":"Blood"},{"issue":"4","key":"2026071611215337400_bib25","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1182\/blood.2020006287","article-title":"Tumor-intrinsic and -extrinsic determinants of response to blinatumomab in adults with B-ALL","volume":"137","author":"Zhao","year":"2021","journal-title":"Blood"},{"issue":"suppl 1","key":"2026071611215337400_bib26","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1182\/blood-2024-207557","article-title":"Assessment of outcomes of allogeneic stem cell transplantation by treatment arm in newly diagnosed measurable residual disease negative patients with B-lineage acute lymphoblastic leukemia randomized to conventional chemotherapy +\/- blinatumomab in the ECOG-ACRIN E1910 phase III National Clinical Trials Network Trial [abstract]","volume":"144","author":"Liedtke","year":"2024","journal-title":"Blood"}],"container-title":["Blood"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/ashpublications.org\/blood\/article-pdf\/148\/3\/289\/2533937\/blood_bld-2026-033309-main.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/ashpublications.org\/blood\/article-pdf\/148\/3\/289\/2533937\/blood_bld-2026-033309-main.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T15:22:02Z","timestamp":1784215322000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/blood\/article\/148\/3\/289\/567951\/Blinatumomab-consolidation-for-high-risk-Ph-B-cell"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,16]]},"references-count":26,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,7,16]]}},"URL":"https:\/\/doi.org\/10.1182\/blood.2026033309","relation":{},"ISSN":["0006-4971","1528-0020"],"issn-type":[{"value":"0006-4971","type":"print"},{"value":"1528-0020","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,7,16]]},"published":{"date-parts":[[2026,7,16]]}}}